CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation ; volume:8 ; number:1 ; day:22 ; month:12 ; year:2009 ; pages:1-14 ; date:12.2009
Molecular cancer ; 8, Heft 1 (22.12.2009), 1-14, 12.2009
- Creator
-
Carlisle, Alex J.
Lyttle, Christopher A.
Carlisle, Rosalind Y.
Maris, John M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-8-126
- URN
-
urn:nbn:de:101:1-2021082720083199958439
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Carlisle, Alex J.
- Lyttle, Christopher A.
- Carlisle, Rosalind Y.
- Maris, John M.
- SpringerLink (Online service)
Other Objects (12)
Heterogeneity of metastogenic neuroblastoma cells
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Two independent epigenetic biomarkers predict survival in neuroblastoma
Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Correction: Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Cyclophosphamide in combination with tumor lysate and TLR9 ligand regresses murine neuroblastoma
Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma
Editorial: The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
Heterogeneity of metastogenic neuroblastoma cells
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Two independent epigenetic biomarkers predict survival in neuroblastoma
Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Correction: Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Cyclophosphamide in combination with tumor lysate and TLR9 ligand regresses murine neuroblastoma
Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma
Editorial: The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
Heterogeneity of metastogenic neuroblastoma cells
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Two independent epigenetic biomarkers predict survival in neuroblastoma
Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Correction: Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Cyclophosphamide in combination with tumor lysate and TLR9 ligand regresses murine neuroblastoma
Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma